COMP <GO>
BHC vs UNH // NET PROFIT MARGIN
Bausch Health Companies Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: BHC 7
— UNH 8
▲ NET PROFIT MARGIN LEADER: UNH
LAST: $8.20 (-7.97%) • MKT CAP: $3.33B
net-margins
1.50%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
net-margins
3.14%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BHC VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BHC | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 88.57% | -47.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.60% | 11.47% | -3.87 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.5x | 16.4x | -5.95 | BHC | /valuation <GO> |
| Free Cash Flow Yield | 22.00% | 6.48% | +15.52 | BHC | /fcf-yield <GO> |
| Operating Margin | 17.70% | 4.82% | +12.88 | BHC | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 1.50% | 3.14% | -1.64 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 6.70% | 6.46% | +0.24 | BHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 3.12 | -2.67 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | BHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.74% | +0.06 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 72.3 | 56.0 | +16.25 | BHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 0.33 | +0.64 | BHC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.7x | 17.1x | +2.61 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.33B | $364.66B | -$361.32B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BHC REV | UNH REV | BHC GROSS % | UNH GROSS % | BHC FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.27B | $447.57B | 44.0% | 88.7% | $1.00B | $16.07B |
| FY 2024 | $9.63B | $400.28B | 44.0% | 88.3% | $1.26B | $20.70B |
| FY 2023 | $8.76B | $371.62B | 44.0% | 89.6% | $637.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BHC // BETA 0.97
UNH // BETA 0.33